211 related articles for article (PubMed ID: 11286676)
1. Creating therapeutic cancer vaccines: notes from the battlefield.
Overwijk WW; Restifo NP
Trends Immunol; 2001 Jan; 22(1):5-7. PubMed ID: 11286676
[TBL] [Abstract][Full Text] [Related]
2. Tumor escape from the immune response: a major hurdle for successful immunotherapy of cancer?
Chouaib S
Tunis Med; 2005 Dec; 83 Suppl 12():7-10. PubMed ID: 16430055
[No Abstract] [Full Text] [Related]
3. Tumour escape from the immune response: the last hurdle for successful immunotherapy of cancer?
Pawelec G
Cancer Immunol Immunother; 1999 Oct; 48(7):343-5. PubMed ID: 10501845
[No Abstract] [Full Text] [Related]
4. [Immune tolerance and active suppression in oncology. Immunological principles and therapeutic options].
Stremmel C; Klein P; Hohenberger W
Chirurg; 2002 Mar; 73(3):255-61. PubMed ID: 11963500
[TBL] [Abstract][Full Text] [Related]
5. Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer.
Nawrocki S; Wysocki PJ; Mackiewicz A
Expert Opin Biol Ther; 2001 Mar; 1(2):193-204. PubMed ID: 11727529
[TBL] [Abstract][Full Text] [Related]
6. Making and circumventing tolerance to cancer.
Kammertoens T; Blankenstein T
Eur J Immunol; 2009 Sep; 39(9):2345-53. PubMed ID: 19634191
[TBL] [Abstract][Full Text] [Related]
7. Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: to use or not to use?
Strioga MM; Darinskas A; Pasukoniene V; Mlynska A; Ostapenko V; Schijns V
Vaccine; 2014 Jul; 32(32):4015-24. PubMed ID: 24837511
[TBL] [Abstract][Full Text] [Related]
8. [Immunotherapy of cancer].
Andersen MH; Schmidt H; Gehl J; von der Maase H; Straten P
Ugeskr Laeger; 2002 Jun; 164(23):3008-16. PubMed ID: 12082849
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
Amedei A; Niccolai E; Prisco D
Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccine for cancer immunotherapy.
Yang B; Jeang J; Yang A; Wu TC; Hung CF
Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
[TBL] [Abstract][Full Text] [Related]
11. "Tumor immunology meets oncology (TIMO) VI" from 7th to 8th of May 2010 in Halle, Germany.
Quandt D; Massa C; Seliger B
Cancer Immunol Immunother; 2011 Feb; 60(2):299-303. PubMed ID: 20803010
[No Abstract] [Full Text] [Related]
12. Spinning molecular immunology into successful immunotherapy.
Pardoll DM
Nat Rev Immunol; 2002 Apr; 2(4):227-38. PubMed ID: 12001994
[TBL] [Abstract][Full Text] [Related]
13. Tumor immunology--towards a paradigm of reciprocal research.
Drake CG; Pardoll DM
Semin Cancer Biol; 2002 Feb; 12(1):73-80. PubMed ID: 11926415
[TBL] [Abstract][Full Text] [Related]
14. Antitumour immune response and cancer vaccination: the critical role of dendritic cells.
Kochman S; Bernard J
Curr Med Res Opin; 1999; 15(4):321-6. PubMed ID: 10640266
[TBL] [Abstract][Full Text] [Related]
15. Immune based therapies in cancer.
Krüger C; Greten TF; Korangy F
Histol Histopathol; 2007 Jun; 22(6):687-96. PubMed ID: 17357098
[TBL] [Abstract][Full Text] [Related]
16. Advances in Therapeutic Cancer Vaccines.
Wong KK; Li WA; Mooney DJ; Dranoff G
Adv Immunol; 2016; 130():191-249. PubMed ID: 26923002
[TBL] [Abstract][Full Text] [Related]
17. Addressing tumour tolerance to improve cancer immunotherapy.
Meyer RG; Herr W
Eur J Immunol; 2010 Dec; 40(12):3302-5. PubMed ID: 21110313
[No Abstract] [Full Text] [Related]
18. Tumor vaccines in 2010: need for integration.
Koos D; Josephs SF; Alexandrescu DT; Chan RC; Ramos F; Bogin V; Gammill V; Dasanu CA; De Necochea-Campion R; Riordan NH; Carrier E
Cell Immunol; 2010; 263(2):138-47. PubMed ID: 20434139
[TBL] [Abstract][Full Text] [Related]
19. Vaccines for established cancer: overcoming the challenges posed by immune evasion.
van der Burg SH; Arens R; Ossendorp F; van Hall T; Melief CJ
Nat Rev Cancer; 2016 Apr; 16(4):219-33. PubMed ID: 26965076
[TBL] [Abstract][Full Text] [Related]
20. Cancer immunotherapy: moving forward with peptide T cell vaccines.
Kumai T; Fan A; Harabuchi Y; Celis E
Curr Opin Immunol; 2017 Aug; 47():57-63. PubMed ID: 28734176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
